US 11058670
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
granted A61KA61K31/437A61K31/4745
Quick answer
US patent 11058670 (Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator) held by Corcept Therapeutics Incorporated expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/437, A61K31/4745, A61P, A61P5/44